Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Ballinger

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 6, 2001
A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheresZ Liu, R Cheung, X Y Wu, et al.
Bioconjugate Chemistry|September 20, 2000
A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cellsZ F Su, J R Ballinger, A M Rauth, et al.
Cancer Research|April 20, 2001
Hypoxia in radiation-induced blood-spinal cord barrier breakdownY Q Li, J R Ballinger, R A Nordal, et al.
European Journal of Nuclear Medicine|January 1, 1990
In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTcM Ecclestone, A Proulx, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cellsJ R Ballinger, J Bannerman, I Boxen, et al.
Bioconjugate Chemistry|September 30, 1999
Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxiaZ F Su, X Zhang, J R Ballinger, et al.
Bioconjugate Chemistry|May 23, 2000
Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicityX Zhang, Z F Su, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECTM Ichise, J R Ballinger, H Golan, et al.
Magnetic Resonance Imaging|January 1, 1995
P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude miceJ R Ballinger, H Kang, C A Sweeney, et al.
European Journal of Nuclear Medicine|February 24, 2001
Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell lineK Utsunomiya, J R Ballinger, M Piquette-Miller, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 6, 2001
A study of doxorubicin loading onto and release from sulfopropyl dextran ion-exchange microspheresZ Liu, R Cheung, X Y Wu, et al.
Bioconjugate Chemistry|September 20, 2000
A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cellsZ F Su, J R Ballinger, A M Rauth, et al.
Cancer Research|April 20, 2001
Hypoxia in radiation-induced blood-spinal cord barrier breakdownY Q Li, J R Ballinger, R A Nordal, et al.
European Journal of Nuclear Medicine|January 1, 1990
In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTcM Ecclestone, A Proulx, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1996
Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cellsJ R Ballinger, J Bannerman, I Boxen, et al.
Bioconjugate Chemistry|September 30, 1999
Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxiaZ F Su, X Zhang, J R Ballinger, et al.
Bioconjugate Chemistry|May 23, 2000
Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicityX Zhang, Z F Su, J R Ballinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1996
Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECTM Ichise, J R Ballinger, H Golan, et al.
Magnetic Resonance Imaging|January 1, 1995
P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude miceJ R Ballinger, H Kang, C A Sweeney, et al.
European Journal of Nuclear Medicine|February 24, 2001
Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell lineK Utsunomiya, J R Ballinger, M Piquette-Miller, et al.
Pageof 9